We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
Colleges and universities can apply for grants from the U.S. Department of Education to support programs that seek to reduce high-risk drinking and violent behavior among college students.
The U.S. Department of Justice's Office of Juvenile Justice and Delinquency Prevention (OJJDP) will award grants of up to $200,000 under its Gang Prevention Coordination and Assistance Program.
The U.S. Department of Education is now accepting applications for its Safe Schools/Healthy Students Program, which supports development and implementation of comprehensive, community-wide plans to create safe and drug-free schools and promote healthy childhood development.
The National Center on Addiction and Substance Abuse (CASA) at Columbia University announced that Join Together will be merged into CASA and David L. Rosenbloom, Ph.D., will become the President and Chief Executive Officer of CASA. Joseph A. Califano, Jr., the former U.S. Secretary of Health, Education, and Welfare who founded CASA in 1992 and has been its Chairman and President since that time, will continue to serve as CASA chairman.
The use of long-term opioid agonist and partial agonist medication is often reserved for older opioid-dependent individuals, while a brief detoxification with medication or medication-free treatment is offered to younger individuals. In a randomized trial, researchers evaluated the efficacy of buprenorphine-naloxone tapers of 2 versus 12 weeks in younger subjects.
Substance use during pregnancy remains a serious problem. This study examined whether Early Start, a coordinated program of prenatal substance abuse screening, treatment, and patient/provider education improved perinatal outcomes.
Brief intervention (BI) can decrease alcohol consumption among some patients with nondependent unhealthy use. But does BI have efficacy for illicit drugs? The World Health Organization published the first randomized trial of drug BI.
The role of individual substances on human immunodeficiency virus (HIV) disease progression has been a complicated puzzle. This study looks at the impact of crack cocaine use among HIV-positive women in the Women's Interagency Cohort Study between 1996 and 2004, the era of highly active antiretroviral therapy.
Patients in treatment for substance use disorders have a high prevalence of smoking. Treating nicotine dependence in substance abuse treatment (SAT) settings, however, is uncommon. Researchers conducted a randomized trial to evaluate the effectiveness of a smoking cessation intervention in SAT programs.
Studies of persons with hypertension have demonstrated a reduction in blood pressure if heavy alcohol consumption is reduced or eliminated, but few studies have focused on persons who met criteria for alcohol dependence. This large, multi-center study of alcohol dependence treatment analyzed data over a 16-week treatment period.
New York's Medicaid program has long hindered comprehensive treatment for people with co-occurring addiction and mental-health problems, but now the state is training more counselors to provide services to dually diagnosed patients.
Needle-exchange programs have been credited with saving many lives by preventing the spread of HIV/AIDS among injection-drug users, but some counselors at the harm-reduction programs have been fatally tempted by easy availability of heroin.
The state of New Mexico will issue ID cards to medical-marijuana users, allow qualified patients to grow their own marijuana, and permit nonprofit groups to produce and distribute the drug to medical users under final regulations released last week.
This website uses cookies. We use cookies and similar technologies to give you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
